Comment on: "COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population".

Am J Ophthalmol

Department of Ophthalmology (A.H., C.L., N.H., C.L., Y.T.), China Medical University Hospital, China Medical University, Taichung, Taiwan; School of Medicine, College of Medicine (C.L., N.H., C.L., Y.T.), China Medical University, Taichung, Taiwan; Department of Optometry (C.L., N.H., C.L., Y.T.), A

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajo.2025.04.025DOI Listing

Publication Analysis

Top Keywords

comment "covid-19
4
"covid-19 vaccination
4
vaccination ocular
4
ocular adverse
4
adverse events
4
events self-controlled
4
self-controlled case
4
case series
4
series study
4
study entire
4

Similar Publications

GenPad: A Highly Efficient Roadmap for the Development of a New Rapid, Highly Sensitive, and Portable Point-of-Care Testing System for Nucleic Acid Diagnostics in Japan.

Diagnostics (Basel)

August 2025

Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

From the corona virus pandemic in Japan that started with the "Diamond Princess" accident, it became clear that rapid detection, a high sensitivity, multiple diagnostic items, one-step one-base point mutation detection, a fast speed of system development, portability (small size and light weight), full automation, random access, and other conditions are required for future point-of-care testing systems. The Eprimer-SmartAmp technology that was developed possesses characteristics fully aligned with these requirements. Building upon this platform, the "GenPad" system was subsequently established.

View Article and Find Full Text PDF